Pulmonary Fibrosis/Interstitial Lung Disease

Interstitial Lung Disease/Pulmonary Fibrosis/Sarcoidosis
The Interstitial Lung Disease Program at UAB

Vision Statement
To become a World-class center of excellence in patient care, research and education in Interstitial Lung Disease.


1. To provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD).
2. To discover and develop new and effective therapies for interstitial lung diseases, particularly idiopathic pulmonary fibrosis (IPF) and sarcoidosis.
3. To better understand disease mechanisms through translational research.
4. To educate physicians in training.
5. To reach out to the community aiming to enhance ILD awareness and help improve the standards for evaluation, treatment and follow up of patients.


Joao A. de Andrade, MD - Director

Joseph B. Barney, MD - Director of the Sarcoidosis Clinic

Victor J. Thannickal, MD

Tracy Luckhardt, MD

Louise Hecker, PhD - Drug Discovery Program

Tonja Meadows, RN - Clinical Research Coordinator

Mae E. Stewart, CTS - Study Coordinator

Angela Lewis, RN - Study Coordinator 

Contact information
UAB Interstitial Lung Disease Program
THT 422, 1900 University Boulevard
Birmingham, AL 35294-0006
Phone: (205) 934 7557
Fax: (205) 934 6229

Email: tmeadows@uab.edu

SOM Epilogue Menu